1Cademy - Tocilizumab (TCZ) infusion dosage for study of outcomes among 100 severe COVID-19 patients in Brescia, Italy

Learn Before

Methods for tracking outcomes among 100 severe COVID-19 patients in Brescia, Italy 24–72 h after Tocilizumab (TCZ) infusion

Concept

Tocilizumab (TCZ) infusion dosage for study of outcomes among 100 severe COVID-19 patients in Brescia, Italy

"TCZ was administered at a dosage of 8 mg/kg (max 800 mg) by two consecutive intravenous infusions 12 h apart. A third infusion, 24 h apart from the second was optional based on clinical response."

Updated 2020-06-15

Contributors are:

Lisa Mayer

🏆 1

Who are from:

University of Michigan - Ann Arbor

🏆 1

References

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

Learn Before

Related